Results: According to the answers of the participants, it was concluded that the symptoms could persist for more than 1 month and therefore they repeatedly applied to the hospital. Conclusion: The uncertainty about the symptoms and duration of COVID-19 after treatment imposes serious...
The aim of this study was to assess postacute coronavirus disease 2019 (COVID-19) syndrome (PACS) symptoms according to the onset of the infection while evaluating the effect of COVID-19 vaccination on the symptoms of PACS. We conducted a retrospective single-center cohort study in which non...
Infection with SARS-CoV-2 virus is associated with a wide range of symptoms. The REal-time Assessment of Community Transmission −1 (REACT-1) study monitored the spread and clinical manifestation of SARS-CoV-2 among random samples of the population in England from 1 May 2020 to 31 March ...
Onerecent studyled by the CDC's Mark Thompson, closely following essential and frontline workers through April, found the risk of symptoms and duration of illness was much lower among most vaccinated participants with breakthrough cases. Thompson said in an email that the CDC is still studying br...
19 cohort, including 187 patients [47]. In their patient experience survey study, Sirotich et al. reported that 465 patients with rheumatic diseases had a diagnosis of COVID-19 based on symptoms or physician diagnosis with positive laboratory tests [46]. However, no further details were ...
1 Shared decision-making regarding timing of surgery after SARS-CoV-2 infection between patient and multidisciplinary clinical teams must consider: severity of the initial infection; ongoing symptoms of COVID- 19; comorbid and functional status, both before and after SARS-CoV-2 infection; clinical ...
An evaluation of the effects of saffron supplementation on the asthma clinical symptoms and asthma severity in patients with mild and moderate persistent allergic asthma: a double-blind, randomized placebo-controlled trial Respir. Res., 20 (39) (2019) Google Scholar [426] M. Ghiasian, F. Khami...
VID-19 deterioration. Furthermore, severe COVID-19 symptoms were more likely to be observed in patients suffering metastatic or stage IV cancers than in those with localized malignancies [16]. Moreover, therapeutic approaches, such as surgery, chemotherapy, radiotherapy, and immunotherapy have been ...
People with dementia experienced worsened neuropsychiatric symptoms since the outbreak of COVID-19, most commonly, depression, apathy, delusions, anxiety, irritability, and agitation. Regression analyses revealed that limited understanding of the COVID-19 situation and not living with the carer was ...
were the most discriminative symptoms for COVID-19. Additional discriminative symptoms included self-reported headache and fatigue and a documentation of syncope, rhinorrhea and fever. Children had a significantly shorter disease duration. Several symptoms were reported weeks after recovery. By a unique ...